Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.
about
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsPrevention of Community-Acquired Pneumonia with Available Pneumococcal VaccinesEpidemiology, virulence factors and management of the pneumococcusThe potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experienceRespiratory risks from household air pollution in low and middle income countriesEstimating the population-level impact of vaccines using synthetic controls.Appropriateness of administrative data for vaccine impact evaluation: the case of pneumonia hospitalizations and pneumococcal vaccine in Brazil.Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.Challenges to estimating vaccine impact using hospitalization data.Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children BrazilReduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern BrazilAll-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?Deconstructing the differences: a comparison of GBD 2010 and CHERG's approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies.Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil.Reply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children"Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya.Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.Characteristics of serogroup 20 S.pneumoniae isolates from Brazil.Risk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control studyImpact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review.Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.Methods and challenges for the health impact assessment of vaccination programs in Latin AmericaSurveillance of the impact of pneumococcal conjugate vaccines in developing countriesResponse to Wu et al. - Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong.Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children.Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines.Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies.10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.Streptococcus pneumoniae serotype 19A: Worldwide epidemiology.Bayesian model averaging with change points to assess the impact of vaccination and public health interventions.Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.Rapid Decrease in Rates of Hospitalization Resulting From Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Children Aged <60 Months After 13-Valent Pneumococcal Conjugate Vaccine Introduction in Argentina.Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006-2014.Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine.Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries.Improving Assessments of Population-level Vaccine Impact.
P2860
Q26744448-A93B4FC4-13DF-4871-88A2-A8386CDD433DQ28077703-EC7FAF2E-404C-4DFF-B90A-EB584D9EDD18Q28078832-8475FEA2-D249-40EC-9663-C30A87FFCB3EQ28088507-22EB97D0-ECCD-4139-9266-9D1B185D2D7EQ28391847-04D8885B-132B-497B-8619-F9545A82E5D8Q30398164-8E7858F8-A0CF-4917-B4C2-60A8841AF40EQ30807600-0B9889FE-4740-4C8D-88C2-852C314A04C8Q31072053-959BC31D-7126-4FB5-8F84-34F507D448CBQ31145427-0F8286E4-0335-475D-9C8C-4D5929B9575BQ33706645-BD39B0DF-731C-492C-8245-BAE7500B460FQ33778646-B056E24E-A5BB-4B65-8EB2-3314950DE575Q34428419-5CBB66C4-984D-4C8F-8C41-7620EC643027Q34473127-256D06DF-E83E-4D33-9D22-2904D4FD929DQ34798448-F8865DF2-D037-4826-917E-2B30C7F79DA6Q35008712-F6E8BE36-DA01-4F3C-96E5-10979474D89BQ35675286-7BB4F5C6-325B-48BD-BEDF-997A4C482C31Q35752770-F384950C-05C7-4FD4-8C25-580C5CD55F2DQ35824048-522B34C6-9E2F-4B37-8133-9A3656CFFAC8Q35887689-C06987F5-B9CE-4F65-8E8F-635E6467BCE6Q36104413-31A8A756-999C-4B8D-AC66-281F87C81CE2Q36141815-A42D049E-ACCD-494E-8635-2114142E5AB4Q36219932-795EA10E-F6CB-46CC-8D3E-DDB04ABA047AQ36294037-A6BF0121-FC69-43B5-B55A-C71B77A1C42FQ36395006-9419DC49-F4BD-490B-9786-C8AFE8D6FFC2Q37309181-F08A5011-3DF9-4C3F-B069-2DB4E36BA58FQ37375921-6110FDD2-D529-4FEA-8A93-CB570114B79DQ37516888-4FF2A86D-5610-4282-A167-598AD25BB240Q37524274-DC6DBF0A-BED6-4005-842C-D76E771CC0CFQ37663184-4EF35593-1489-46FE-AC5B-10F11BC5FA0EQ37713768-4DF4064F-1740-4EE2-A64C-DDA78372D47CQ38246355-1A412E24-0F73-402C-A688-0EBB4E16880BQ38637072-3E46EBFA-FB45-455C-AA25-A68E6E4B1D66Q38646854-A32634F7-03B8-4A28-B582-D6B4D3682699Q38679715-A58DB13A-44B8-4EEC-8FDD-F4A50AF09BAAQ38878876-8345797D-3EA6-4D12-9A20-155ED7DAE376Q38966571-CC51388F-57E6-48F8-B2CE-2FEA2FADDCBEQ40059651-FFDD9CCC-A529-4F37-8520-B36840CAC538Q40079452-700C7596-26ED-49A9-9E62-E6C15F1CAC2EQ40242598-9208D785-F3E3-48DF-9FC1-B6A157F6FCA3Q40439344-5138D17D-F38E-47A8-A90A-EDA1880E7A08
P2860
Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.
@en
type
label
Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.
@en
prefLabel
Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.
@en
P2093
P2860
P50
P356
P1476
Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.
@en
P2093
Ana Lucia Andrade
Carla Magda Domingues
Cristiana Maria Toscano
Eliane Terezinha Afonso
Juan Jose Cortez Escalante
Otaliba Libanio Morais-Neto
P2860
P304
P356
10.3201/EID1904.121198
P577
2013-04-01T00:00:00Z